NCT06489782
Developing a Novel Human Laboratory Paradigm for AUD Medication Screening
At risk: Primary completion moved 12 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 6 versions: 4 with changes below, 2 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Notable Primary and study completion pushed from Aug 31, 2026 to Aug 31, 2027
- Eligibility criteria expanded, about 15 words
- Study description revised
- Minor Primary and study completion dates pushed to Aug 31, 2026v5
- Notable Trial status: Not Yet Recruiting to Recruiting
- Start date changed from estimate of Sep 15, 2024 to Nov 1, 2024
- Site details revised
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Alcohol consumption
Timeframe: 120 minutes
Arms and interventions
Model 1Experimental
Model 1 examines the impact of alcohol cues and alcohol availability on latency to start drinking and amount consumed of a 0.12 g/dL dose of alcohol during a 2-hour ad-libitum period.
Model 2Experimental
Model 2 examines the impact of alcohol cues and alcohol availability and a priming dose of alcohol (.04 g/dL) on latency to start drinking and amount consumed of a 0.12 g/dL dose of alcohol during a 2-hour ad-libitum period.
Other: Model 1, Model 2
Sites
1 site in 1 country
- Yale UniversityNew Haven, Connecticut, United States